Eli Lilly 2015 Annual Report Download - page 128

P12
John C. Lechleiter, Ph.D., age 62, director since 2005
Board Committees: none
Career Highlights Industry Memberships
Eli Lilly and Company • American Chemical Society; Pharmaceutical Research
and Manufacturers of America (PhRMA); U.S. - Japan
Business Council, chairman
• President and CEO (2008 - present)
• Chairman of the Board (2009 - present)
Honors Other Board Service
• Honorary doctorates: Marian University, University of Indianapolis,
the National University of Ireland, Indiana University, and Franklin
College
•Public boards: Ford Motor Company; Nike, Inc.
•Non-profit boards: United Way Worldwide, chairman;
Chemical Heritage Foundation; and the Central Indiana
Corporate Partnership
Qualifications: Dr. Lechleiter is our chairman, president, and chief executive officer. A Ph.D. chemist by training, Dr. Lechleiter has over
36 years of experience with the company in a variety of roles of increasing responsibility in research and development, pharmaceutical
operations, and corporate administration. As a result, he has a sound understanding of pharmaceutical research and development, sales
and marketing, and manufacturing. He also has significant corporate governance experience through his service on other public
company boards.
Marschall S. Runge, M.D., Ph.D., age 61, director since 2013
Board Committees: Science and Technology; Public Policy and Compliance
Career Highlights Industry Memberships
University of Michigan • Experimental Cardiovascular Sciences Study Section of
the National Institutes of Health
•CEO, University of Michigan Health System (2015 - present)
•Executive Vice President for Medical Affairs (2015 - present)
•Dean, Medical School (2015 - present)
University of North Carolina, School of Medicine
• Executive Dean (2010 - 2015); Chair of the Department of Medicine
(2000 - 2015)
• Principal Investigator and Director of the North Carolina Translational
and Clinical Sciences Institute
Qualifications: Dr. Runge brings the unique perspective of a practicing physician who has a broad background in health care, clinical
research, and academia. He has extensive experience as a practicing cardiologist, and has deep expertise in biomedical research and
clinical trial design.
Class of 2018
The following four directors are serving terms that will expire in May 2018.
Katherine Baicker, Ph.D., age 44, director since 2011
Board Committees: Audit; Public Policy and Compliance
Career Highlights Industry Memberships
Harvard T.H. Chan School of Public Health, Department of Health
Policy and Management
• Commissioner of the Medicare Payment Advisory
Commission
• Professor of health economics (2007 - present) • Chair of the Group Insurance Commission of
Massachusetts
• C. Boyden Gray Professor and Acting Chair, department of Health
Policy and Management (2014 - 2016)
• Panel of Health Advisers to the Congressional Budget
Office
Council of Economic Advisers, Executive Office of the President
• Editorial boards of Health Affairs and the Journal of
Health Economics
• Member (2005 - 2007) • Member of the Institute of Medicine
• Senior Economist (2001 - 2002)
Qualifications: Dr. Baicker is a leading researcher in the fields of health economics, public economics, and labor economics. As a
valued adviser to numerous health care-related commissions and committees, her expertise in health care policy and health care
delivery is recognized in both academia and government.